Penserra Capital Management’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,995
Closed -$11K 1349
2021
Q3
$11K Buy
3,995
+350
+10% +$964 ﹤0.01% 1342
2021
Q2
$13K Buy
3,645
+165
+5% +$588 ﹤0.01% 1249
2021
Q1
$11K Buy
3,480
+160
+5% +$506 ﹤0.01% 1019
2020
Q4
$9K Buy
3,320
+2,100
+172% +$5.69K ﹤0.01% 928
2020
Q3
$3K Buy
+1,220
New +$3K ﹤0.01% 880